🔗 Permalink

Inventor profile of:

Patrick Baeuerle

City:

Gauting

Country:

Germany

Published Applications:

Last publication date:

2025-06-19

Top Assignees for applications by Patrick Baeuerle

The entities that hold a legal rights for patent applications filed by inventor Baeuerle Patrick:

TCR2 THERAPEUTICS INC. 6 Cambridge, MA United States
Werewolf Therapeutics, Inc. 5 Cambridge, MA United States
MICROMET AG 4 Munich, Germany
Harpoon Therapeutics, Inc. 4 South San Francisco, CA United States
Werewolf Therapeutics, Inc. 3 Watertown, MA United States
AMGEN RESEARCH (MUNICH) GMBH 2 Munich, Germany
HARPOON THERAPEUTICS, INC. 1 Brisbane, CA United States
Amgen Inc. 1 Thousand Oaks, CA United States
Takeda Pharmaceutical Company Limited 1 Osaka, Japan
TAKEDA PHARMACEUTICAL COMPANY LIMITED 1 Osaka-shi, Osaka, Japan
AMEGEN INC. 1 Thousand Oaks, CA United States

Recent patent applications by Baeuerle Patrick

Patrick Baeuerle from Gauting, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-06-19

US20250197526A1

Chemistry; metallurgy

TRISPECIFIC BINDING PROTEINS AND METHODS OF USE

#2 | 2025-06-05

US20250179138A1

Chemistry; metallurgy

ACTIVATABLE INTERLEUKIN 12 POLYPEPTIDES AND METHODS OF USE THEREOF

#3 | 2024-09-12

US20240301026A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

#4 | 2023-12-28

US20230414752A1

Human necessities

Constrained conditionally activated binding proteins

#5 | 2023-11-23

US20230374093A1

Chemistry; metallurgy

ACTIVATABLE INTERLEUKIN-2 POLYPEPTIDES AND METHODS OF USE THEREOF

#6 | 2023-07-27

US20230235010A1

Chemistry; metallurgy

Compositions and methods for TCR reprogramming using fusion proteins

#7 | 2023-07-06

US20230212318A1

Chemistry; metallurgy

PROTEASE-ACTIVATABLE BISPECIFIC PROTEINS

#8 | 2023-07-06

US20230212297A1

Chemistry; metallurgy

BISPECIFIC FC MOLECULES

#9 | 2022-10-13

US20220324930A1

Chemistry; metallurgy

Activatable interleukin 12 polypeptides and methods of use thereof

#10 | 2022-09-22

US20220298478A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

#11 | 2022-02-24

US20220056096A1

Chemistry; metallurgy

Activatable interleukin-2 polypeptides and methods of use thereof

#12 | 2021-12-30

US20210403524A1

Chemistry; metallurgy

Activatable interleukin-2 polypeptides and methods of use thereof

#13 | 2021-07-08

US20210206827A9

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

#14 | 2021-06-24

US20210187022A1

Human necessities

ENGINEERED T CELLS FOR THE TREATMENT OF CANCER

#15 | 2021-06-17

US20210179735A1

Chemistry; metallurgy

Trispecific binding proteins and methods of use

#16 | 2021-04-08

US20210100902A1

Human necessities

PROSTATE SPECIFIC MEMBRANE ANTIGEN BINDING PROTEIN

#17 | 2021-04-01

US20210095047A1

Chemistry; metallurgy

PSMA Targeting Trispecific Proteins and Methods of Use

#18 | 2021-03-18

US20210079057A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS

#19 | 2020-11-19

US20200362306A1

Chemistry; metallurgy

Compositions and methods for TCR reprogramming using fusion proteins

#20 | 2020-11-19

US20200362011A1

Chemistry; metallurgy

Compositions and methods for TCR reprogramming using fusion proteins

#21 | 2020-09-10

US20200283490A1

Chemistry; metallurgy

Activatable interleukin-2 polypeptides and methods of use thereof

#22 | 2020-09-10

US20200283489A1

Chemistry; metallurgy

Activatable interleukin 12 polypeptides and methods of use thereof

#23 | 2020-02-06

US20200040052A1

Chemistry; metallurgy

Activatable interleukin-2 polypeptides

#24 | 2019-12-05

US20190367576A1

Chemistry; metallurgy

Activatable interleukin 12 polypeptides

#25 | 2019-09-12

US20190276540A1

Chemistry; metallurgy

Compositions and methods for TCR reprogramming using fusion proteins

#26 | 2019-08-22

US20190256571A1

Chemistry; metallurgy

Compositions and methods for TCR reprogramming using fusion proteins

#27 | 2019-07-25

US20190225702A1

Chemistry; metallurgy

INNATE IMMUNE CELL TRISPECIFIC BINDING PROTEINS AND METHODS OF USE

#28 | 2019-06-13

US20190177694A1

Chemistry; metallurgy

Compositions and methods for TCR reprogramming using fusion proteins

#29 | 2018-06-14

US20180162949A1

Chemistry; metallurgy

PSMA targeting trispecific proteins and methods of use

#30 | 2018-06-14

US20180161428A1

Human necessities

Prostate specific membrane antigen binding protein

#31 | 2018-05-17

US20180134789A1

Chemistry; metallurgy

INDUCIBLE BINDING PROTEINS AND METHODS OF USE

#32 | 2017-10-19

US20170298149A1

Chemistry; metallurgy

Trispecific binding proteins and methods of use

#33 | 2017-08-31

US20170247476A1

Chemistry; metallurgy

PROTEASE-ACTIVATABLE BISPECIFIC PROTEINS

#34 | 2016-11-24

US20160340444A1

Chemistry; metallurgy

Trispecific binding proteins and methods of use

#35 | 2016-05-26

US20160145340A1

Chemistry; metallurgy

BISPECIFIC-FC MOLECULES

#36 | 2013-04-18

US20130095103A1

Human necessities

Means and methods for the treament of B cell non-hodgkin lymphoma and B cell leukemia

#37 | 2009-11-26

US20090291072A1

Human necessities

Means and methods for the treatment of tumorous diseases

#38 | 2008-02-19

US10362591

Composition for the elimination of autoreactive B-cells

#39 | 2007-10-25

US20070249529A1

Chemistry; metallurgy

Compositions comprising polypeptides

#40 | 2007-04-12

US20070081993A1

Chemistry; metallurgy

Pharmaceutical composition comprising a bispecific antibody for EpCAM

#41 | 2006-09-05

US9163713

Nuclear hormone receptor drug screens

#42 | 2006-03-23

US20060062780A1

Chemistry; metallurgy

De-immunized MOG (poly)peptide constructs

InventorID:

196674 ⎘